Song Eun Young, Park Soyun, Lee Dong Soon, Cho Han Ik, Park Myoung Hee
Department of Laboratory Medicine, Konkuk University College of Medicine, Seoul, Korea.
Hum Immunol. 2008 Jun;69(6):354-9. doi: 10.1016/j.humimm.2008.04.009. Epub 2008 May 16.
Although association of human leukocyte antigen (HLA)-DR2 (DRB11501) with susceptibility to aplastic anemia (AA) has been well documented in several different ethnic groups, little is known about the protective role of HLA in this disease. HLA-DRB1 alleles were analyzed in 109 Korean AA patients (26 nonsevere and 83 severe) and 800 healthy controls. The frequency of DRB11501 was significantly higher in AA patients compared with controls [33.0% vs 15.3%, p=0.000004, p(c)=0.0001, odds ratio (OR)=2.74]. Nonsevere AA (30.8%, OR=2.47) and severe AA patients (33.7%, OR=2.83) showed similar changes, and DRB11501 was considered a susceptibility factor to AA in both forms of the disease. The frequency of DRB11302 in total AA patients was not different from controls (12.8% vs 17.9%), but it was significantly lower in severe AA compared with nonsevere AA patients (6.0% vs 34.6%, p=0.0006, p(c)=0.02, OR=0.12). DRB11302 was considered a protective factor against severe AA. In Koreans, DRB11501 was associated with disease susceptibility to AA and DRB1*1302 with protection against the severe form of the disease.
尽管人类白细胞抗原(HLA)-DR2(DRB11501)与再生障碍性贫血(AA)易感性之间的关联在几个不同种族中已有充分记录,但关于HLA在该疾病中的保护作用却知之甚少。对109例韩国AA患者(26例非重型和83例重型)及800例健康对照者进行了HLA-DRB1等位基因分析。与对照组相比,AA患者中DRB11501的频率显著更高[33.0%对15.3%,p=0.000004,p(c)=0.0001,比值比(OR)=2.74]。非重型AA(30.8%,OR=2.47)和重型AA患者(33.7%,OR=2.83)呈现相似变化,且DRB11501在两种疾病形式中均被视为AA的易感因素。AA患者总体中DRB11302的频率与对照组无差异(12.8%对17.9%),但与非重型AA患者相比,重型AA中该频率显著更低(6.0%对34.6%,p=0.0006,p(c)=0.02,OR=0.12)。DRB11302被视为预防重型AA的保护因素。在韩国人中,DRB11501与AA疾病易感性相关,而DRB1*1302与预防该疾病的重型形式相关。